Rare Candace

Rare Candace

An unconventional disruption of rare disease.

Menu

Skip to content
  • Helpful Links
  • About Candace
  • Let’s Connect!

Tag Archives: Sarepta

A Winning Day for Orphan Drugs!

Tweet

 

This morning, the Food and Drug Administration announced that it granted accelerated approval to Sarepta Therapeutics’ drug Eteplirsen. This comes after months of waiting for a decision after an extremely intense Adcomm meeting.  Continue reading →

Posted on September 19, 2016 by RareCandace. | Tagged DMD, Duchenne, Eteplirsen, orphan drugs, Sarepta | Leave a comment

Keep Up to Date With RareCandace

Recent Posts

  • COVID-19 Vaccine Incentives vs Clinical Trial Reimbursement
  • The Harmful Embrace of “One Size Fit All” in Drug Development
  • Do you suffer from Sciatica like me?
  • The Limits of Patient Insights
  • Authentic Communication in Healthcare

Recent Comments

  • aftonbladet on More Than a Patient
  • Buy xanax Online on More Than a Patient
  • Heroin for sale on More Than a Patient
  • How to buy cocaine on More Than a Patient
  • Buy Colombian cocaine online on More Than a Patient

Archives

  • December 2020
  • November 2020
  • September 2020
  • March 2020
  • January 2020
  • November 2019
  • October 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • July 2018
  • May 2018
  • March 2018
  • May 2017
  • September 2016
  • July 2016
  • June 2016
  • April 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014

Categories

  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Proudly powered by WordPress Theme: Publish by Konstantin Kovshenin.